NCT02999373View on ClinicalTrials.gov

Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Bronchopulmonary DysplasiaPrematureNeonatal Death
Interventions
OTHER

Autologous Umbilical Cord Blood Mononuclear Cells Therapy

Autologous Umbilical Cord Blood Mononuclear Cells Therapy in preterm for prevention of infection

Trial Locations (1)

511442

Jie Yang, Guangzhou

All Listed Sponsors
lead

Guangdong Women and Children Hospital

OTHER

NCT02999373 - Autologous Cord Blood Mononuclear Cells for Bronchopulmonary Dysplasia in Very Preterm Neonates | Biotech Hunter | Biotech Hunter